These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey. Park JE, Chiang CE, Munawar M, Pham GK, Sukonthasarn A, Aquino AR, Khoo KL, Chan HW. Eur J Prev Cardiol; 2012 Aug; 19(4):781-94. PubMed ID: 21450606 [Abstract] [Full Text] [Related]
3. Gender and ethnic differences in the control of hyperlipidaemia and other vascular risk factors: insights from the CEntralised Pan-South African survey on tHE Under-treatment of hypercholeSterolaemia (CEPHEUS SA) study. Rapeport N, Schamroth CL, Blom DJ. Cardiovasc J Afr; 2013 Jul; 24(6):238-42. PubMed ID: 24217264 [Abstract] [Full Text] [Related]
8. Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece survey. Elisaf MS, Nikas N. Angiology; 2010 Jul; 61(5):465-74. PubMed ID: 20462896 [Abstract] [Full Text] [Related]
9. Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic. Kiburg KV, Ward GM, O'Neal DN, MacIsaac RJ. Intern Med J; 2018 Feb; 48(2):201-204. PubMed ID: 29415350 [Abstract] [Full Text] [Related]
11. Achieving low-density lipoprotein cholesterol treatment goals among dyslipidemic individuals in the Levant: the CEntralized Pan-Levant survey on tHE Undertreatment of hypercholeSterolemia (CEPHEUS) study. Hammoudeh AJ, Echtay A, Ghanem GY, Haddad J, CEPHEUS-Levant survey investigators. Curr Med Res Opin; 2014 Oct; 30(10):1957-65. PubMed ID: 24889279 [Abstract] [Full Text] [Related]
12. Lipid attainment among patients newly treated with lipid-altering drugs. Hess G, Chang CL, Chung K. Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282 [Abstract] [Full Text] [Related]
13. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary. Mark L, Vallejo-Vaz AJ, Reiber I, Paragh G, Kondapally Seshasai SR, Ray KK. Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441 [Abstract] [Full Text] [Related]
17. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study. Ferrières J, Rouyer MV, Lautsch D, Ashton V, Ambegaonkar BM, Brudi P, Gitt AK, Dyslipidemia International Study (DYSIS) II France Study Group. Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375 [Abstract] [Full Text] [Related]
19. Gaps in Dyslipidemia Care Among Working-Aged Individuals With Employer-Sponsored Health Care. Shiffman D, Louie JZ, Devlin JJ, Knowles JW, McPhaul MJ. J Am Heart Assoc; 2020 May 05; 9(9):e015807. PubMed ID: 32319337 [Abstract] [Full Text] [Related]
20. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP. Wens J, Gerard R, Vandenberghe H. Prim Care Diabetes; 2011 Apr 05; 5(1):19-24. PubMed ID: 21030327 [Abstract] [Full Text] [Related] Page: [Next] [New Search]